L am Kong is the chairman and chief executive of China Medical System Holdings (CMS), a leading pharmaceutical services provider based in Shenzhen and listed in Hong Kong. He founded the company in 1995 after graduating from Zhanjiang Medical College with a degree in clinical medicine. Under his leadership, CMS has developed a robust business model focused on the promotion and distribution of innovative drugs in the Chinese market.

The company partners with global pharmaceutical firms to bring their products to China's vast healthcare network. Lam took the company public on the Hong Kong Stock Exchange in 2010. He has guided CMS through continuous growth, making it one of the most successful drug commercialization platforms in China. He also holds a significant stake in Tibet Rhodiola Pharmaceutical.